Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hyo-Pyo Lee
Association Between Excision Repair Cross-Complementation Group 1 Polymorphism and Clinical Outcome of Platinum-Based Chemotherapy in Patients With Epithelial Ovarian Cancer
Experimental & Molecular Medicine
Related publications
Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for Non Small-Cell Lung Cancer
Biomarker Insights
Biochemistry
Molecular Medicine
Pharmacology
Excision Repair Cross-Complementing Group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin
Oncotarget
Oncology
Prognostic Value of Excision Repair Cross-Complementation Group 1 Expression in Gastric Cancer: A Meta-Analysis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Association Studies of Excision Repair Cross-Complementation Group 1 (ERCC1) Haplotypes With Lung and Head and Neck Cancer Risk in a Caucasian Population
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
The Prognostic and Predictive Value of Excision Repair Cross-Complementation Group 1 (ERCC1) Protein in 1288 Patients With Head and Neck Squamous Cell Carcinoma Treated With Platinum-Based Therapy: A Meta-Analysis
European Archives of Oto-Rhino-Laryngology
Medicine
Otorhinolaryngology
Expression of Excision Repair Cross-Complementation Group�1 and Class�III Β-Tubulin in Thymic Carcinoma
Oncology Letters
Cancer Research
Oncology
Interrogation of Nucleotide Excision Repair Capacity: Impact on Platinum-Based Cancer Therapy
Antioxidants and Redox Signaling
Cell Biology
Molecular Biology
Biochemistry
Clinical Biochemistry
Medicine
Physiology
Association Between IHC and MSI Testing to Identify Mismatch Repair–Deficient Patients With Ovarian Cancer
Genetic Testing and Molecular Biomarkers
Medicine
Genetics
Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology